Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F S Pedersen

Showing results (31-40 of 99) with videos related to

Pageof 10
Sort By:
Journal of Virology|April 29, 1998
Single amino acid insertion in loop 4 confers amphotropic murine leukemia virus receptor function upon murine Pit1M D Lundorf, F S Pedersen, B O'Hara, et al.
Nucleic Acids Research|December 11, 1992
Determination of recognition-sequences for DNA-binding proteins by a polymerase chain reaction assisted binding site selection method (BSS) using nitrocellulose immobilized DNA binding proteinP L Nørby, N Pallisgaard, F S Pedersen, et al.
Molecular and Cellular Biology|August 1, 1992
Murine helix-loop-helix transcriptional activator proteins binding to the E-box motif of the Akv murine leukemia virus enhancer identified by cDNA cloningA L Nielsen, N Pallisgaard, F S Pedersen, et al.
Gene|January 1, 1986
Mammalian expression-and-transmission vector derived from Akv murine leukemia virusN A Jensen, P Jørgensen, N O Kjeldgaard, et al.
Journal of Virology|September 1, 1988
A nucleotide substitution in the gag N terminus of the endogenous ecotropic DBA/2 virus prevents Pr65gag myristylation and virus replicationE C Jørgensen, N O Kjeldgaard, F S Pedersen, et al.
Journal of Virology|January 7, 2000
Mutations of the kissing-loop dimerization sequence influence the site specificity of murine leukemia virus recombination in vivoJ G Mikkelsen, A H Lund, M Duch, et al.
Journal of Virology|August 1, 1991
SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virusB Hallberg, J Schmidt, A Luz, et al.
Human Gene Therapy|December 16, 1998
RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypesW Uckert, G Willimsky, F S Pedersen, et al.
Journal of Virology|October 6, 1997
Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivoS Ethelberg, J Lovmand, J Schmidt, et al.
Journal of Virology|February 1, 1991
Analysis of the significance of two single-base-pair differences in the SL3-3 and Akv virus long terminal repeatsH L Morrison, H Y Dai, F S Pedersen, et al.
Pageof 10

Showing results (31-40 of 99) with videos related to

Sort By:
Pageof 10
Journal of Virology|April 29, 1998
Single amino acid insertion in loop 4 confers amphotropic murine leukemia virus receptor function upon murine Pit1M D Lundorf, F S Pedersen, B O'Hara, et al.
Nucleic Acids Research|December 11, 1992
Determination of recognition-sequences for DNA-binding proteins by a polymerase chain reaction assisted binding site selection method (BSS) using nitrocellulose immobilized DNA binding proteinP L Nørby, N Pallisgaard, F S Pedersen, et al.
Molecular and Cellular Biology|August 1, 1992
Murine helix-loop-helix transcriptional activator proteins binding to the E-box motif of the Akv murine leukemia virus enhancer identified by cDNA cloningA L Nielsen, N Pallisgaard, F S Pedersen, et al.
Gene|January 1, 1986
Mammalian expression-and-transmission vector derived from Akv murine leukemia virusN A Jensen, P Jørgensen, N O Kjeldgaard, et al.
Journal of Virology|September 1, 1988
A nucleotide substitution in the gag N terminus of the endogenous ecotropic DBA/2 virus prevents Pr65gag myristylation and virus replicationE C Jørgensen, N O Kjeldgaard, F S Pedersen, et al.
Journal of Virology|January 7, 2000
Mutations of the kissing-loop dimerization sequence influence the site specificity of murine leukemia virus recombination in vivoJ G Mikkelsen, A H Lund, M Duch, et al.
Journal of Virology|August 1, 1991
SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virusB Hallberg, J Schmidt, A Luz, et al.
Human Gene Therapy|December 16, 1998
RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypesW Uckert, G Willimsky, F S Pedersen, et al.
Journal of Virology|October 6, 1997
Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivoS Ethelberg, J Lovmand, J Schmidt, et al.
Journal of Virology|February 1, 1991
Analysis of the significance of two single-base-pair differences in the SL3-3 and Akv virus long terminal repeatsH L Morrison, H Y Dai, F S Pedersen, et al.
Pageof 10